Term Name: | gartisertib |
---|---|
Synonyms: | 2-amino-6-fluoro-N-(5-fluoro-4-(4-(4-(oxetan-3-yl)piperazine-1-carbonyl)piperidin-1-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-amino-6-fluoro-N-[5-fluoro-4-(4-{[4-(oxetan-3-yl)piperazin-1-yl]carbonyl}piperidin-1-yl)pyridin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide, gartisertib, gartisertibum, M 4344, M-4344, M4344, VX-803 |
Definition: | Gartisertib is an inhibitor of ataxia telangiectasia and Rad3 related (ATR) kinase, which blocks CHK1 phosphorylation, for purposes relating to programmed cell death of tumor cells. This is an orally administered chemical. |
Ontology: | ChEBI [CHEBI:231616] ( EBI ) |